Jonathan David Spicer
Montreal General Hospital · 342 works · 13,478 citations · h-index 48
Top works
- Targeting potential drivers of COVID-19: Neutrophil extracellular traps
- Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
- Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
- A Systematic Review of the Effects of Resident Duty Hour Restrictions in Surgery
- Perioperative Nivolumab in Resectable Lung Cancer
- Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
- Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms
- Neutrophils Promote Liver Metastasis via Mac-1–Mediated Interactions with Circulating Tumor Cells
- Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
- Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
- LPS-Induced TLR4 Signaling in Human Colorectal Cancer Cells Increases β1 Integrin-Mediated Cell Adhesion and Liver Metastasis
- Neoadjuvant Chemoimmunotherapy for NSCLC
- Association between pathologic response and survival after neoadjuvant therapy in lung cancer
- Neutrophil extracellular traps in cancer progression
- Abstract CT003: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment (tx) for resectable (IB-IIIA) non-small cell lung cancer (NSCLC) in the phase 3 CheckMate 816 trial
- Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).
- Single-cell spatial landscapes of the lung tumour immune microenvironment
- Neutrophil extracellular traps sequester circulating tumor cells via β1-integrin mediated interactions
- SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
- Predictors of survival following surgical resection of limited-stage small cell lung cancer